RABGGTA
Basic information
Region (hg38): 14:24265538-24271611
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RABGGTA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 46 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 46 | 0 | 1 |
Variants in RABGGTA
This is a list of pathogenic ClinVar variants found in the RABGGTA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-24265662-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
14-24265710-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
14-24265710-G-C | not specified | Uncertain significance (Oct 06, 2024) | ||
14-24265752-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
14-24265753-C-G | not specified | Uncertain significance (Dec 10, 2024) | ||
14-24266459-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
14-24266460-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
14-24266478-C-T | not specified | Uncertain significance (Oct 09, 2024) | ||
14-24266786-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
14-24266825-T-C | not specified | Uncertain significance (May 27, 2022) | ||
14-24267683-G-A | not specified | Uncertain significance (Oct 30, 2024) | ||
14-24267689-C-T | not specified | Uncertain significance (Dec 20, 2024) | ||
14-24267701-T-A | not specified | Uncertain significance (May 06, 2022) | ||
14-24267710-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
14-24267723-C-G | not specified | Uncertain significance (Jul 12, 2023) | ||
14-24267736-C-T | not specified | Uncertain significance (Feb 13, 2025) | ||
14-24267760-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
14-24267773-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
14-24267893-G-C | not specified | Uncertain significance (Jan 18, 2025) | ||
14-24267905-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
14-24268150-T-A | not specified | Uncertain significance (May 13, 2024) | ||
14-24268390-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
14-24268399-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
14-24268412-C-T | not specified | Uncertain significance (Feb 07, 2025) | ||
14-24268417-C-A | not specified | Uncertain significance (Sep 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RABGGTA | protein_coding | protein_coding | ENST00000399409 | 16 | 6202 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.75e-10 | 0.990 | 124624 | 0 | 51 | 124675 | 0.000205 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.530 | 307 | 334 | 0.918 | 0.0000207 | 3583 |
Missense in Polyphen | 93 | 110.06 | 0.84496 | 1200 | ||
Synonymous | 0.679 | 129 | 139 | 0.927 | 0.00000778 | 1179 |
Loss of Function | 2.47 | 22 | 38.5 | 0.571 | 0.00000241 | 363 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000203 | 0.000203 |
Ashkenazi Jewish | 0.000398 | 0.000398 |
East Asian | 0.000304 | 0.000278 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.000170 | 0.000168 |
Middle Eastern | 0.000304 | 0.000278 |
South Asian | 0.000409 | 0.000392 |
Other | 0.000497 | 0.000495 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transfer of a geranylgeranyl moiety from geranylgeranyl diphosphate to both cysteines of Rab proteins with the C-terminal sequence -XXCC, -XCXC and -CCXX, such as RAB1A, RAB3A, RAB5A and RAB7A. {ECO:0000269|PubMed:7991565}.;
- Pathway
- TP53 Regulates Transcription of Cell Death Genes;Gene expression (Transcription);Generic Transcription Pathway;Post-translational protein modification;Metabolism of proteins;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Transcriptional Regulation by TP53;RAB geranylgeranylation;Signaling events mediated by PRL
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- rvis_EVS
- -0.75
- rvis_percentile_EVS
- 13.67
Haploinsufficiency Scores
- pHI
- 0.309
- hipred
- N
- hipred_score
- 0.372
- ghis
- 0.552
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.656
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rabggta
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; pigmentation phenotype;
Gene ontology
- Biological process
- cellular protein modification process;visual perception;protein geranylgeranylation;regulation of apoptotic process;post-translational protein modification;protein-containing complex assembly
- Cellular component
- nucleoplasm;cytoplasm;cytosol;plasma membrane;Rab-protein geranylgeranyltransferase complex
- Molecular function
- Rab geranylgeranyltransferase activity;zinc ion binding;Rab GTPase binding;protein heterodimerization activity